Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
RITUXIMAB-PVVR 500 MG/50ML IV SOLN (NDC 00069024901) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved October 17, 2026 , from http://ppman.hank.ai/transparency/procedure/00069024901/by-state?code_type=NDC
“RITUXIMAB-PVVR 500 MG/50ML IV SOLN (NDC 00069024901) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/00069024901/by-state?code_type=NDC. Accessed
October 17, 2026 .
“RITUXIMAB-PVVR 500 MG/50ML IV SOLN (NDC 00069024901) by State,” HANK Price Transparency ,
accessed October 17, 2026 ,
http://ppman.hank.ai/transparency/procedure/00069024901/by-state?code_type=NDC.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
NDC · across United States
00069024901 — Rituximab-pvvr 500 Mg/50ml IV Soln
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$4,852
National median
$57 – $6,341
IQR (p25 – p75)
23
hospitals filing
8
states
Walking in without insurance?
Cash / self-pay price
Cash median
$4,232
vs. negotiated
-12.8%
Hospitals reporting
30
Cash / self-pay rates apply when you don't run the bill through insurance.
Many hospitals also offer income-based discounts on top of the published
cash price — always ask about a financial-assistance application
before paying.
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 00069024901 (NDC), with interquartile range
State Median p25 p75
IA $7,512 $6,536 $9,381
AL $6,989 $5,214 $9,435
CA $5,548 $5,113 $6,363
MI $5,455 $4,434 $6,816
OH $4,668 $22 $6,518
NV $2,652 $1,911 $3,474
FL $41 $32 $54
OR $1 $0 $1